Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-127198
Filing Date
2024-11-14
Accepted
2024-11-14 17:14:01
Documents
55
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hcwb-20240930.htm   iXBRL 10-Q 1392623
2 EX-10.5 hcwb-ex10_5.htm EX-10.5 39234
3 EX-10.6 hcwb-ex10_6.htm EX-10.6 258415
4 EX-31.1 hcwb-ex31_1.htm EX-31.1 15259
5 EX-31.2 hcwb-ex31_2.htm EX-31.2 15137
6 EX-32.1 hcwb-ex32_1.htm EX-32.1 9836
7 EX-32.2 hcwb-ex32_2.htm EX-32.2 9586
8 GRAPHIC img176362979_0.jpg GRAPHIC 62072
9 GRAPHIC img176362979_1.jpg GRAPHIC 50526
10 GRAPHIC img176362979_2.jpg GRAPHIC 47114
11 GRAPHIC img176362979_3.jpg GRAPHIC 14766
12 GRAPHIC img176362979_4.jpg GRAPHIC 20997
13 GRAPHIC img176362979_5.jpg GRAPHIC 16992
14 GRAPHIC img176362979_6.jpg GRAPHIC 21565
15 GRAPHIC img176362979_7.jpg GRAPHIC 16781
16 GRAPHIC img176362979_8.jpg GRAPHIC 52474
  Complete submission text file 0000950170-24-127198.txt   5424557

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20240930.xsd EX-101.SCH 768150
57 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20240930_htm.xml XML 472297
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40591 | Film No.: 241464259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)